A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
The purpose of this study is to evaluate the safety and efficacy of the REG1 anticoagulation System in Acute Coronary Syndrome (ACS) patients undergoing cardiac catheterization.
Primary Outcome Bleeding Secondary Outcome Ischemia
Inclusion Criteria:
Chest pain or other ischemic symptoms a minimum of 10 minutes in duration within 72 hours before anticipated cardiac catheterization;
At least one of the following criteria are met:
Exclusion Criteria:
Gainsville, Florida 32610-0277, United States
Chapel Hill, North Carolina 27599-7075, United States
Magdeburg, 39120, Germany
München, 81377, Germany